Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 202 entries
Sorted by: Best Match Show Resources per page
A morphologic study of the ductus of the epididymis of Sus domesticus.

Journal of morphology

Briz M, Bonet S, Fradera A.
PMID: 29865439
J Morphol. 1993 Feb;215(2):183-193. doi: 10.1002/jmor.1052150206.

The head, body, and tail regions of the epididymal duct (or caput, corpus, and cauda epididymis) in two healthy and sexually mature Sus domesticus males were examined by light microscopy and by scanning or transmission electron microscopy. The epididymal...

Cite
Briz M, Bonet S, Fradera A. A morphologic study of the ductus of the epididymis of Sus domesticus. J Morphol. 1993;215(2):183-193doi: 10.1002/jmor.1052150206.
Briz, M., Bonet, S., & Fradera, A. (1993). A morphologic study of the ductus of the epididymis of Sus domesticus. Journal of morphology, 215(2), 183-193. https://doi.org/10.1002/jmor.1052150206
Briz, M, et al. "A morphologic study of the ductus of the epididymis of Sus domesticus." Journal of morphology vol. 215,2 (1993): 183-193. doi: https://doi.org/10.1002/jmor.1052150206
Briz M, Bonet S, Fradera A. A morphologic study of the ductus of the epididymis of Sus domesticus. J Morphol. 1993 Feb;215(2):183-193. doi: 10.1002/jmor.1052150206. PMID: 29865439.
Copy Download .nbib Format: NLM
Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort.

The Journal of urology

Duquesne I, Pinar U, Dang VT, Mauger de Varennes A, Benali NA, Berchiche W, Margue G, Gaillard C, Bardet F, Hulin M, Manuguerra A, Plassais C, Wandoren W, Lannes F, Khene ZE, Pradere B.
PMID: 34398666
J Urol. 2021 Dec;206(6):1461-1468. doi: 10.1097/JU.0000000000002142. Epub 2021 Aug 16.

PURPOSE: We evaluate the safety of immediate contralateral orchiopexy (ICLO) at the time of scrotal exploration for testicular torsion suspicion.MATERIALS AND METHODS: Patient data were retrieved from the TORSAFUF cohort project, which is a multicenter national study conducted at...

Cite
Duquesne I, Pinar U, Dang VT, et al. Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort. J Urol. 2021;206(6):1461-1468doi: 10.1097/JU.0000000000002142.
Duquesne, I., Pinar, U., Dang, V. T., Mauger de Varennes, A., Benali, N. A., Berchiche, W., Margue, G., Gaillard, C., Bardet, F., Hulin, M., Manuguerra, A., Plassais, C., Wandoren, W., Lannes, F., Khene, Z. E., & Pradere, B. (2021). Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort. The Journal of urology, 206(6), 1461-1468. https://doi.org/10.1097/JU.0000000000002142
Duquesne, Igor, et al. "Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort." The Journal of urology vol. 206,6 (2021): 1461-1468. doi: https://doi.org/10.1097/JU.0000000000002142
Duquesne I, Pinar U, Dang VT, Mauger de Varennes A, Benali NA, Berchiche W, Margue G, Gaillard C, Bardet F, Hulin M, Manuguerra A, Plassais C, Wandoren W, Lannes F, Khene ZE, Pradere B. Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort. J Urol. 2021 Dec;206(6):1461-1468. doi: 10.1097/JU.0000000000002142. Epub 2021 Aug 16. PMID: 34398666.
Copy Download .nbib Format: NLM
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis.

European urology oncology

Laukhtina E, Shim SR, Mori K, D'Andrea D, Soria F, Rajwa P, Mostafaei H, Compérat E, Cimadamore A, Moschini M, Teoh JY, Enikeev D, Xylinas E, Lotan Y, Palou J, Gontero P, Babjuk M, Witjes JA, Kamat AM, Roupret M, Shariat SF, Pradere B.
PMID: 34753702
Eur Urol Oncol. 2021 Nov 06; doi: 10.1016/j.euo.2021.10.003. Epub 2021 Nov 06.

CONTEXT: During the past decade, several urinary biomarker tests (UBTs) for bladder cancer have been developed and made commercially available. However, none of these is recommended by international guidelines so far.OBJECTIVE: To assess the diagnostic estimates of novel commercially...

Cite
Laukhtina E, Shim SR, Mori K, et al. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol. 2021;doi: 10.1016/j.euo.2021.10.003.
Laukhtina, E., Shim, S. R., Mori, K., D'Andrea, D., Soria, F., Rajwa, P., Mostafaei, H., Compérat, E., Cimadamore, A., Moschini, M., Teoh, J. Y., Enikeev, D., Xylinas, E., Lotan, Y., Palou, J., Gontero, P., Babjuk, M., Witjes, J. A., Kamat, A. M., Roupret, M., Shariat, S. F., Pradere, B. (2021). Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. European urology oncology, . https://doi.org/10.1016/j.euo.2021.10.003
Laukhtina, Ekaterina, et al. "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis." European urology oncology vol. (2021). doi: https://doi.org/10.1016/j.euo.2021.10.003
Laukhtina E, Shim SR, Mori K, D'Andrea D, Soria F, Rajwa P, Mostafaei H, Compérat E, Cimadamore A, Moschini M, Teoh JY, Enikeev D, Xylinas E, Lotan Y, Palou J, Gontero P, Babjuk M, Witjes JA, Kamat AM, Roupret M, Shariat SF, Pradere B. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol. 2021 Nov 06; doi: 10.1016/j.euo.2021.10.003. Epub 2021 Nov 06. PMID: 34753702.
Copy Download .nbib Format: NLM
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.

European urology focus

Mori K, Schuettfort VM, Katayama S, Laukhtina E, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P, König F, Aydh A, Soria F, Moschini M, Karakiewicz PI, Lotan Y, Scherr D, Haydter M, Nyirady P, Teoh JYC, Egawa S, Compérat E, Shariat SF.
PMID: 34454852
Eur Urol Focus. 2021 Aug 25; doi: 10.1016/j.euf.2021.08.006. Epub 2021 Aug 25.

BACKGROUND: Elevated preoperative plasma levels of the angiogenesis-related marker VEGF have been associated with worse oncological outcomes in various malignancies.OBJECTIVE: To investigate the predictive/prognostic role of VEGF in patients with urothelial carcinoma of the bladder (UCB) treated with radical...

Cite
Mori K, Schuettfort VM, Katayama S, et al. The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. Eur Urol Focus. 2021;doi: 10.1016/j.euf.2021.08.006.
Mori, K., Schuettfort, V. M., Katayama, S., Laukhtina, E., Pradere, B., Quhal, F., Sari Motlagh, R., Mostafaei, H., Grossmann, N. C., Rajwa, P., König, F., Aydh, A., Soria, F., Moschini, M., Karakiewicz, P. I., Lotan, Y., Scherr, D., Haydter, M., Nyirady, P., Teoh, J. Y. C., Egawa, S., Compérat, E., & Shariat, S. F. (2021). The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. European urology focus, . https://doi.org/10.1016/j.euf.2021.08.006
Mori, Keiichiro, et al. "The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy." European urology focus vol. (2021). doi: https://doi.org/10.1016/j.euf.2021.08.006
Mori K, Schuettfort VM, Katayama S, Laukhtina E, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P, König F, Aydh A, Soria F, Moschini M, Karakiewicz PI, Lotan Y, Scherr D, Haydter M, Nyirady P, Teoh JYC, Egawa S, Compérat E, Shariat SF. The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. Eur Urol Focus. 2021 Aug 25; doi: 10.1016/j.euf.2021.08.006. Epub 2021 Aug 25. PMID: 34454852.
Copy Download .nbib Format: NLM
Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base.

Proceedings of the National Academy of Sciences of the United States of America

Astley CM, Tuli G, Mc Cord KA, Cohn EL, Rader B, Varrelman TJ, Chiu SL, Deng X, Stewart K, Farag TH, Barkume KM, LaRocca S, Morris KA, Kreuter F, Brownstein JS.
PMID: 34903657
Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2111455118.

Simultaneously tracking the global impact of COVID-19 is challenging because of regional variation in resources and reporting. Leveraging self-reported survey outcomes via an existing international social media network has the potential to provide standardized data streams to support monitoring...

Cite
Astley CM, Tuli G, Mc Cord KA, et al. Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base. Proc Natl Acad Sci U S A. 2021;118(51)doi: 10.1073/pnas.2111455118.
Astley, C. M., Tuli, G., Mc Cord, K. A., Cohn, E. L., Rader, B., Varrelman, T. J., Chiu, S. L., Deng, X., Stewart, K., Farag, T. H., Barkume, K. M., LaRocca, S., Morris, K. A., Kreuter, F., & Brownstein, J. S. (2021). Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base. Proceedings of the National Academy of Sciences of the United States of America, 118(51), . https://doi.org/10.1073/pnas.2111455118
Astley, Christina M, et al. "Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base." Proceedings of the National Academy of Sciences of the United States of America vol. 118,51 (2021). doi: https://doi.org/10.1073/pnas.2111455118
Astley CM, Tuli G, Mc Cord KA, Cohn EL, Rader B, Varrelman TJ, Chiu SL, Deng X, Stewart K, Farag TH, Barkume KM, LaRocca S, Morris KA, Kreuter F, Brownstein JS. Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base. Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2111455118. PMID: 34903657.
Copy Download .nbib Format: NLM
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma.

Clinical genitourinary cancer

Mori K, Katayama S, Laukhtina E, Schuettfort VM, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P, Zimmermann K, Karakiewicz PI, Abufaraj M, Fajkovic H, Rouprêt M, Margulis V, Enikeev DV, Egawa S, Shariat SF.
PMID: 34764007
Clin Genitourin Cancer. 2021 Oct 10; doi: 10.1016/j.clgc.2021.10.002. Epub 2021 Oct 10.

INTRODUCTION: This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).PATIENTS AND METHODS: Records of 1,214 UTUC patients who had undergone...

Cite
Mori K, Katayama S, Laukhtina E, et al. Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2021;doi: 10.1016/j.clgc.2021.10.002.
Mori, K., Katayama, S., Laukhtina, E., Schuettfort, V. M., Pradere, B., Quhal, F., Sari Motlagh, R., Mostafaei, H., Grossmann, N. C., Rajwa, P., Zimmermann, K., Karakiewicz, P. I., Abufaraj, M., Fajkovic, H., Rouprêt, M., Margulis, V., Enikeev, D. V., Egawa, S., & Shariat, S. F. (2021). Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. Clinical genitourinary cancer, . https://doi.org/10.1016/j.clgc.2021.10.002
Mori, Keiichiro, et al. "Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma." Clinical genitourinary cancer vol. (2021). doi: https://doi.org/10.1016/j.clgc.2021.10.002
Mori K, Katayama S, Laukhtina E, Schuettfort VM, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann NC, Rajwa P, Zimmermann K, Karakiewicz PI, Abufaraj M, Fajkovic H, Rouprêt M, Margulis V, Enikeev DV, Egawa S, Shariat SF. Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2021 Oct 10; doi: 10.1016/j.clgc.2021.10.002. Epub 2021 Oct 10. PMID: 34764007.
Copy Download .nbib Format: NLM
Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer.

World journal of urology

Baron P, Khene Z, Lannes F, Pignot G, Bajeot AS, Ploussard G, Verhoest G, Gasmi A, Perrot O, Roumiguie M, Mori K, Cacciamani GE, Rouprêt M, Bruyère F, Pradere B.
PMID: 34216242
World J Urol. 2021 Dec;39(12):4335-4344. doi: 10.1007/s00345-021-03753-y. Epub 2021 Jul 03.

OBJECTIVE: To perform an external validation of this RC-pentafecta.METHOD: Between January 2014 and December 2019, 104 consecutive patients who underwent RARC with ICUD within 6 urological centers were analyzed retrospectively. Patients who simultaneously demonstrated negative soft tissue surgical margins...

Cite
Baron P, Khene Z, Lannes F, et al. Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer. World J Urol. 2021;39(12):4335-4344doi: 10.1007/s00345-021-03753-y.
Baron, P., Khene, Z., Lannes, F., Pignot, G., Bajeot, A. S., Ploussard, G., Verhoest, G., Gasmi, A., Perrot, O., Roumiguie, M., Mori, K., Cacciamani, G. E., Rouprêt, M., Bruyère, F., & Pradere, B. (2021). Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer. World journal of urology, 39(12), 4335-4344. https://doi.org/10.1007/s00345-021-03753-y
Baron, P, et al. "Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer." World journal of urology vol. 39,12 (2021): 4335-4344. doi: https://doi.org/10.1007/s00345-021-03753-y
Baron P, Khene Z, Lannes F, Pignot G, Bajeot AS, Ploussard G, Verhoest G, Gasmi A, Perrot O, Roumiguie M, Mori K, Cacciamani GE, Rouprêt M, Bruyère F, Pradere B. Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer. World J Urol. 2021 Dec;39(12):4335-4344. doi: 10.1007/s00345-021-03753-y. Epub 2021 Jul 03. PMID: 34216242; PMCID: PMC8602171.
Copy Download .nbib Format: NLM
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.

BJU international

Schuettfort VM, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF.
PMID: 33650265
BJU Int. 2021 Mar 01; doi: 10.1111/bju.15379. Epub 2021 Mar 01.

OBJECTIVES: To determine the predictive and prognostic value of a panel of systemic inflammatory response (SIR) biomarkers relative to established clinicopathological variables in order to improve patient selection and facilitate more efficient delivery of peri-operative systemic therapy.MATERIALS AND METHODS:...

Cite
Schuettfort VM, D'Andrea D, Quhal F, et al. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. BJU Int. 2021;doi: 10.1111/bju.15379.
Schuettfort, V. M., D'Andrea, D., Quhal, F., Mostafaei, H., Laukhtina, E., Mori, K., König, F., Rink, M., Abufaraj, M., Karakiewicz, P. I., Luzzago, S., Rouprêt, M., Enikeev, D., Zimmermann, K., Deuker, M., Moschini, M., Sari Motlagh, R., Grossmann, N. C., Katayama, S., Pradere, B., & Shariat, S. F. (2021). A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. BJU international, . https://doi.org/10.1111/bju.15379
Schuettfort, Victor M, et al. "A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma." BJU international vol. (2021). doi: https://doi.org/10.1111/bju.15379
Schuettfort VM, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. BJU Int. 2021 Mar 01; doi: 10.1111/bju.15379. Epub 2021 Mar 01. PMID: 33650265.
Copy Download .nbib Format: NLM
Transurethral laser ablation of the prostate: from "which technique does better" to "what patient benefits the most" the real challenge in contemporary surgery.

World journal of urology

Misrai V, Pradere B.
PMID: 32959069
World J Urol. 2021 Dec;39(12):4507-4508. doi: 10.1007/s00345-020-03455-x. Epub 2020 Sep 21.

No abstract available.

Cite
Misrai V, Pradere B. Transurethral laser ablation of the prostate: from "which technique does better" to "what patient benefits the most" the real challenge in contemporary surgery. World J Urol. 2020;39(12):4507-4508doi: 10.1007/s00345-020-03455-x.
Misrai, V., & Pradere, B. (2021). Transurethral laser ablation of the prostate: from "which technique does better" to "what patient benefits the most" the real challenge in contemporary surgery. World journal of urology, 39(12), 4507-4508. https://doi.org/10.1007/s00345-020-03455-x
Misrai, Vincent, and Pradere, Benjamin. "Transurethral laser ablation of the prostate: from "which technique does better" to "what patient benefits the most" the real challenge in contemporary surgery." World journal of urology vol. 39,12 (2021): 4507-4508. doi: https://doi.org/10.1007/s00345-020-03455-x
Misrai V, Pradere B. Transurethral laser ablation of the prostate: from "which technique does better" to "what patient benefits the most" the real challenge in contemporary surgery. World J Urol. 2021 Dec;39(12):4507-4508. doi: 10.1007/s00345-020-03455-x. Epub 2020 Sep 21. PMID: 32959069.
Copy Download .nbib Format: NLM
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.

Critical reviews in oncology/hematology

Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF.
PMID: 34902554
Crit Rev Oncol Hematol. 2021 Dec 10;169:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub 2021 Dec 10.

OBJECTIVE: To determine the oncologic and toxicity outcomes of adjuvant immunotherapy with immune checkpoint inhibitors (ICIs) compared to adjuvant chemotherapy in patients treated with radical surgery for urothelial carcinoma (UC).METHODS: We used the Bayesian approach in the network meta-analysis...

Cite
Laukhtina E, Sari Motlagh R, Mori K, et al. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Crit Rev Oncol Hematol. 2021;169:103570doi: 10.1016/j.critrevonc.2021.103570.
Laukhtina, E., Sari Motlagh, R., Mori, K., Katayama, S., Rajwa, P., Yanagisawa, T., Quhal, F., Mostafaei, H., Grossmann, N. C., König, F., Aydh, A., Pradere, B., Resch, I., Merseburger, A. S., Enikeev, D., & Shariat, S. F. (2021). Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Critical reviews in oncology/hematology, 169103570. https://doi.org/10.1016/j.critrevonc.2021.103570
Laukhtina, Ekaterina, et al. "Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes." Critical reviews in oncology/hematology vol. 169 (2021): 103570. doi: https://doi.org/10.1016/j.critrevonc.2021.103570
Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Crit Rev Oncol Hematol. 2021 Dec 10;169:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub 2021 Dec 10. PMID: 34902554.
Copy Download .nbib Format: NLM
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis.

Journal of clinical medicine

Krajewski W, Nowak Ł, Moschini M, Poletajew S, Chorbińska J, Necchi A, Montorsi F, Briganti A, Sanchez-Salas R, Shariat SF, Palou J, Babjuk M, Teoh JY, Soria F, Pradere B, Ornaghi PI, Pawlak A, Dembowski J, Zdrojowy R.
PMID: 33567656
J Clin Med. 2021 Feb 08;10(4). doi: 10.3390/jcm10040651.

BACKGROUND: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) with pelvic lymph-node dissection is the standard treatment for cT2-4a cN0 cM0 muscle-invasive bladder cancer (MIBC). Despite the significant improvement of primary-tumor downstaging with NAC, up to 50% of...

Cite
Krajewski W, Nowak Ł, Moschini M, et al. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis. J Clin Med. 2021;10(4)doi: 10.3390/jcm10040651.
Krajewski, W., Nowak, �. �., Moschini, M., Poletajew, S., Chorbińska, J., Necchi, A., Montorsi, F., Briganti, A., Sanchez-Salas, R., Shariat, S. F., Palou, J., Babjuk, M., Teoh, J. Y., Soria, F., Pradere, B., Ornaghi, P. I., Pawlak, A., Dembowski, J., & Zdrojowy, R. (2021). Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis. Journal of clinical medicine, 10(4), . https://doi.org/10.3390/jcm10040651
Krajewski, Wojciech, et al. "Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis." Journal of clinical medicine vol. 10,4 (2021). doi: https://doi.org/10.3390/jcm10040651
Krajewski W, Nowak Ł, Moschini M, Poletajew S, Chorbińska J, Necchi A, Montorsi F, Briganti A, Sanchez-Salas R, Shariat SF, Palou J, Babjuk M, Teoh JY, Soria F, Pradere B, Ornaghi PI, Pawlak A, Dembowski J, Zdrojowy R. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis. J Clin Med. 2021 Feb 08;10(4). doi: 10.3390/jcm10040651. PMID: 33567656; PMCID: PMC7915645.
Copy Download .nbib Format: NLM
Paradigm shift in efforts to end TB by 2025.

The Indian journal of tuberculosis

Sachdeva KS, Parmar M, Rao R, Chauhan S, Shah V, Pirabu R, Balasubramaniam D, Vadera B, Anand S, Mathew M, Solanki H, Sundar VV.
PMID: 33308672
Indian J Tuberc. 2020 Dec;67(4):S48-S60. doi: 10.1016/j.ijtb.2020.11.001. Epub 2020 Nov 10.

TB is a deadly infectious disease, in existence since time immemorial. This article traces the journey of TB developments in the last few decades and the path breaking moments that have accelerated the efforts towards Ending TB from National...

Cite
Sachdeva KS, Parmar M, Rao R, et al. Paradigm shift in efforts to end TB by 2025. Indian J Tuberc. 2020;67(4):S48-S60doi: 10.1016/j.ijtb.2020.11.001.
Sachdeva, K. S., Parmar, M., Rao, R., Chauhan, S., Shah, V., Pirabu, R., Balasubramaniam, D., Vadera, B., Anand, S., Mathew, M., Solanki, H., & Sundar, V. V. (2020). Paradigm shift in efforts to end TB by 2025. The Indian journal of tuberculosis, 67(4), S48-S60. https://doi.org/10.1016/j.ijtb.2020.11.001
Sachdeva, K S, et al. "Paradigm shift in efforts to end TB by 2025." The Indian journal of tuberculosis vol. 67,4 (2020): S48-S60. doi: https://doi.org/10.1016/j.ijtb.2020.11.001
Sachdeva KS, Parmar M, Rao R, Chauhan S, Shah V, Pirabu R, Balasubramaniam D, Vadera B, Anand S, Mathew M, Solanki H, Sundar VV. Paradigm shift in efforts to end TB by 2025. Indian J Tuberc. 2020 Dec;67(4):S48-S60. doi: 10.1016/j.ijtb.2020.11.001. Epub 2020 Nov 10. PMID: 33308672.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 202 entries